Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
NCT00005861
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
NETWORK
Sponsor class
Conditions
Endometrial Cancer
Interventions
DRUG:
pegylated liposomal doxorubicin hydrochloride
Sponsor
Gynecologic Oncology Group
Collaborators
[object Object]